Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer

NCT01989845 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

127

Enrollment

OTHER

Sponsor class

Conditions

Rivaroxaban
Cancer-associated Thrombosis
Recurrence
Bleeding

Interventions

DRUG: Rivaroxaban

Sponsor

Seoul National University Hospital

Collaborators

[object Object]